Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism.
Case Rep Neurol
; 8(3): 185-192, 2016.
Article
em En
| MEDLINE
| ID: mdl-27790123
ABSTRACT
We describe a 29-year-old female who presented with rhabdomyolysis shortly after starting a course of sodium valproate. A thorough investigation revealed a likely mitochondrial origin inducing this susceptibility. An underlying mitochondrial disorder should be considered in all patients who present with undifferentiated disease whilst taking sodium valproate.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article